Best Building Product Companies To Own In Right Now

Best Building Product Companies To Own In Right Now: Novavax Inc.(NVAX)

Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant vaccines for infectious diseases using its virus-like particle platform (VLP) technology. It develops vaccine product candidates that target pandemic influenza, including H1N1 and H5N1 strains; seasonal influenza; and respiratory syncytial virus (RSV). Novavax has a joint venture with Cadila Pharmaceuticals Ltd. to develop and manufacture the company?s pandemic and seasonal influenza vaccine candidates, Cadila?s biogeneric products, and other diagnostic products for the territory of India; and a licensing agreement with LG Life Sciences, Ltd. to use the company?s VLP technology to develop and sell the company?s influenza vaccines in South Korea and other countries. It also has a co-marketing agreement with GE Healthcare for a pandemic influenza vaccine solution. The company was founded in 1987 and is headquartered in Rockville, Maryland.

Advisors' Opinion:

• [By Jayson Derrick]

  Novavax (NASDAQ: NVAX) said that it plans to begin a Phase 1 clinical trial of its Ebola vaccine as early as December. Shares gained 13.06 percent, closing at $5.80.

• [By Rich Bieglmeier]

  [Related -Novavax, Inc. (NVAX): Insider Buying News You Can Use]

  Novavax is a clinical-stage biopharmaceutical company focused on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases. The company's technology platform is based on proprietary recombinant vaccine technology that includes virus-like particles (VLPs) and recombinant protein micelle vaccines. Its vaccine candidates target seasonal influenza, pandemic (H5N1) influenza, and respiratory syncytial virus (RSV).

• [By Susan J. Aluise]

  Given the sheer profit potential of this sector, all ! investors should have some exposure to biotech stocks, but your investment horizon and risk tolerance is almost certainly going to differ from the next guy. So, if you’re looking for ideas of biotech stocks to buy, here are a few suggestions — some for conservative investors, and some for the truly adventurous:

  Biotech Stocks: Novavax (NVAX)
  

  Type: Small-cap stock
  Market Cap: $972 million

source from Top Stocks For 2015:http://www.topstocksblog.com/best-building-product-companies-to-own-in-right-now-3.html